Systemic therapy for cholangiocarcinoma.
作者信息
Sadeghi Saeed, Finn Richard S
机构信息
Department of Medicine, Division of Hematology/ Oncology Geffen School of Medicine at UCLA Los Angeles CA.
出版信息
Clin Liver Dis (Hoboken). 2014 Apr 28;3(4):86-89. doi: 10.1002/cld.337. eCollection 2014 Apr.
Abstract
摘要
相似文献
1
Systemic therapy for cholangiocarcinoma.胆管癌的全身治疗
Clin Liver Dis (Hoboken). 2014 Apr 28;3(4):86-89. doi: 10.1002/cld.337. eCollection 2014 Apr.
2
Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.肝内胆管癌的全身治疗和辅助治疗
Cancer Control. 2017 Jul-Sep;24(3):1073274817729241. doi: 10.1177/1073274817729241.
3
Locoregional therapy for cholangiocarcinoma.局部区域治疗胆管癌。
Curr Opin Gastroenterol. 2013 May;29(3):324-8. doi: 10.1097/MOG.0b013e32835d9dea.
4
The current role of radiotherapy and systemic therapy in the multidisciplinary treatment of cholangiocarcinoma.放射治疗和全身治疗在胆管癌多学科治疗中的当前作用。
Cas Lek Cesk. 2019 Spring;158(2):78-82.
5
Systemic therapy for locally advanced and metastatic cholangiocarcinoma.局部晚期和转移性胆管癌的全身治疗
Asian Pac J Cancer Prev. 2012;13 Suppl:3-6.
6
Systemic therapy for hepatocellular carcinoma and cholangiocarcinoma.肝细胞癌和胆管癌的全身治疗。
Surg Oncol Clin N Am. 2015 Jan;24(1):187-98. doi: 10.1016/j.soc.2014.09.009. Epub 2014 Oct 12.
7
Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.分割放射治疗联合腺病毒介导的胞嘧啶脱氨酶基因和5-氟胞嘧啶给药可增强人结直肠癌和胆管癌模型中的细胞毒性和抗肿瘤作用。
Gene Ther. 2000 Jun;7(12):1019-26. doi: 10.1038/sj.gt.3301196.
8
Systemic Therapy for Primary Liver Tumors: Cholangiocarcinoma and Hepatocellular Carcinoma.原发性肝脏肿瘤的全身治疗：胆管癌和肝细胞癌
Surg Oncol Clin N Am. 2019 Oct;28(4):695-715. doi: 10.1016/j.soc.2019.06.015.
9
Multimodal Therapy including Yttrium-90 Radioembolization as a Bridging Therapy to Liver Transplantation for a Huge and Locally Advanced Intrahepatic Cholangiocarcinoma.钇-90 放射性栓塞联合多模态治疗作为巨大局部进展性肝内胆管细胞癌肝移植桥接治疗
J Gastrointestin Liver Dis. 2016 Sep;25(3):401-4. doi: 10.15403/jgld.2014.1121.253.y90.
10
Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: A prospective study.使用血卟啉光动力疗法治疗不可切除的肝外胆管癌：一项前瞻性研究。
Photodiagnosis Photodyn Ther. 2016 Dec;16:110-118. doi: 10.1016/j.pdpdt.2016.10.001. Epub 2016 Oct 5.
本文引用的文献
1
Pathogenesis, diagnosis, and management of cholangiocarcinoma.胆管癌的发病机制、诊断和治疗。
Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15.
2
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.辅助治疗在胆道癌治疗中的应用：系统评价和荟萃分析。
J Clin Oncol. 2012 Jun 1;30(16):1934-40. doi: 10.1200/JCO.2011.40.5381. Epub 2012 Apr 23.
3
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.吉西他滨和奥沙利铂联合或不联合厄洛替尼治疗晚期胆道癌的多中心、开放标签、随机、3 期研究。
Lancet Oncol. 2012 Feb;13(2):181-8. doi: 10.1016/S1470-2045(11)70301-1. Epub 2011 Dec 20.
4
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.胆管癌的基因组和遗传学特征鉴定出酪氨酸激酶抑制剂的治疗靶点。
Gastroenterology. 2012 Apr;142(4):1021-1031.e15. doi: 10.1053/j.gastro.2011.12.005. Epub 2011 Dec 13.
5
Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer.吉西他滨联合伊立替康作为一线化疗治疗晚期胆道癌的前瞻性 II 期临床试验。
Chemotherapy. 2011;57(3):236-43. doi: 10.1159/000328021. Epub 2011 May 19.
6
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers.多机构Ⅱ期研究塞来替尼治疗转移性胆道癌患者。
J Clin Oncol. 2011 Jun 10;29(17):2357-63. doi: 10.1200/JCO.2010.33.9473. Epub 2011 Apr 25.
7
Risk factors for cholangiocarcinoma.胆管癌的危险因素。
Hepatology. 2011 Jul;54(1):173-84. doi: 10.1002/hep.24351.
8
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.西妥昔单抗、吉西他滨和奥沙利铂治疗不可切除的晚期或转移性胆道癌患者：一项 2 期研究。
Lancet Oncol. 2010 Dec;11(12):1142-8. doi: 10.1016/S1470-2045(10)70247-3. Epub 2010 Nov 9.
9
A multicenter phase II trial with irinotecan plus oxaliplatin as first-line treatment for inoperable/metastatic cancer of the biliary tract.一项多中心二期临床试验，采用伊立替康联合奥沙利铂作为不可切除/转移性胆道癌的一线治疗。
Oncology. 2010;78(5-6):356-60. doi: 10.1159/000320462. Epub 2010 Aug 26.
10
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.顺铂联合吉西他滨与吉西他滨治疗胆管癌。
N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.
Zotero 插件